Cookies policy statement
We are using cookies on our site to provide you with the best user experience.
Disabling cookies may prevent our website from working efficiently. Click ok to remove this message (we will remember your choice).

NHS European Office 

The NHS European Office provides the essential link between European policy and NHS organisations

The European Office is based in Brussels and London and is part of the NHS Confederation.

The Office covers a wide range of EU policy and legislative developments which have implications for the NHS, with a dedicated section on the NHS Employers website also covering European employment policy issues. In addition we offer a range of opportunities for NHS organisations to engage with EU affairs, to access EU support for innovation and to get involved in our work.

Latest news 

European Parliament approves new law on clinical trials 

Following lengthy negotiations, the European Parliament voted on 2 April 2014 to approve a new EU law regulating the conduct of clinical trials. The new Regulation simplifies existing authorisation procedures and for the first time introduces the concept of co-sponsorship of trials, the model widely used by NHS trusts who often lead clinical trials in partnership with academia. Read our press release and find out more on our clinical trials page.

European Parliament votes on proposals for Tobacco Directive 

On 26 February 2014, the full European Parliament voted to adopt the compromise text of the Tobacco Products Directive, informally agreed at EU level on18 December 2013.  The text includes combined picture and text health warnings to cover 65 % of the front and the back of tobacco and cigarette packages, as well as extending the legislation to cover electronic cigarettes. The agreed text is expected to be approved by the Council of Ministers in mid-March. Read more.

Innovation Expo 2014 

The NHS European Office spoke on the EU funding opportunites for research available to NHS organisations at the 2014 Innovation Expo which took place in Manchester at the beginning of March, an annual event showcasing the latest innovations in health and care. View our presentation from the event and find out more on EU funding from our webpage.

Joint statement on Data Protection Regulation

The NHS European Office has joined forces with non-commercial research organisations and academics to voice concerns over several of the amendments contained in the proposed EU Regulation on data protection. The amendments, if implemented, could have a detrimental effect on future health research. Read more.

European Parliament votes on new public procurement rules

On 15 January 2014, the European Parliament voted to approve new EU rules for public bodies when buying goods and services.The new EU Directive on public procurement intends to make the process of purchasing  goods and services by public bodies - such as NHS organisations - faster, more flexible and more effective. Among other measures, the new rules allow purchasers greater opportunities to negotiate with bidders during the selection process and enable public bodies to pool their activities without always having to go out to tender. Read our press release and download our briefing from the public procurement page. 

European Commission launches first calls for projects under Horizon 2020

The European Commission has published the first calls for projects under Horizon 2020, its new funding programme for research and innovation for the next seven years. The first calls focus on twelve areas, including personalising health and care, which aims to develop better health promotion and disease prevention strategies, as well as developing technologies to support healthy ageing. The European Office has published a briefing on the funding opportunities available to NHS organisations under the Horizon 2020 programme and further information is available on our Horizon 2020 web page.

Greece and Ireland referred to European Court

The European Commission has decided to refer both Greece and Ireland to the European Court of Justice for their failure to comply with the limits imposed on the working hours of hospital doctors contained in the Working Time Directive (WTD).  Many European countries are finding it difficult to comply with the rigid restrictions on working time contained in the WTD and the European Office has long campaigned on behalf of the NHS for a common-sense relaxation of some of the rules to better fit services that operate 24 hours, such as healthcare. See our page for more on the Working Time Directive.  

Lessons from Europe: new briefings available

The European Office has published a further 2 briefings from its Lessons from Europe series of seminars, which it organised with LSE Health and the Health Services Research Network. The seminars aimed to demonstrate how health policy experience from Europe could be applied in practice in health organisations in England and heard from experts from several European countries on a range of health issues. Download the briefings

NHS European Office secures changes to new EU rules on professional mobility

A final vote in the European Parliament on 9 October 2013 has agreed the new rules governing the movement of healthcare professionals across Europe. The vote follows months of negotiations and the NHS European Office engaged significantly with the Directive, securing important changes for the NHS, including whether and when incoming migrants can be subjected to language checks, mechanisms to prevent bad healthcare professionals from travelling to other EU countries to treat patients and the minimum standards for length and content of training.

The NHS European Office has produced a briefing which provides an overview of the key aspects of the new Directive and its implications for NHS organisations. See our press release and our page on the mobility of healthcare professionals.

New symbol to identify medicines undergoing additional monitoring

From September 1st 2013, a new symbol will appear on medicines which will allow patients and medical professionals to identify medicinal products that are subject to additional monitoring. Taking the form of an inverted triangle, the symbol will appear on the inside leaflet and the accompanying text will encourage patients and medical professionals to report any unexpected adverse reactions through national reporting systems. Read more.

EU Parliament vote secures continued patient access to MRI scanners

Following a successful campaign by the NHS European Office, the European Parliament voted on 11 June 2013 to allow continued patient access to life-saving MRI treatments, while at the same time protecting staff working with MRI scanners from adverse effects and risks to their health and safety. See our press release


Register   Forgotten Password?    



Share |